NVIDIA CEO Jensen Huang to a standing room only room riffs to laughs on not talking to his usual crowd here at #JPM24 “Target, inhibit … the list of words you guys use are just generally angry.”

What kind of business really NEEDS VC money? - Deeptech & hardware: High risk, high costs, long time to market. - "Winner-takes-all" marketplaces à la Uber until they reach scale Who else?

Always a good day when you get to meet the CEO of @Nvidia!

Awesome meeting you Chris Gibson !!

Stevie Cline We’re actually working on a fusion reactor to power quantum computer (made of room temp superconductors of course) to design 3D printed food that we then attach to a drone powered by AI that drops it off at @spaceX and then launch it to your house, lands in your backyard where

Amazing way to cap off JPM Healthcare Week in SF with some of the coolest GPs, founders and investors in town for our closing Brexfast Chris Leiter Obvious Ventures Brex

New 8VC gear just dropped 🔥

#BWHpublication Leveraging artificial intelligence in neurosurgery—unveiling ChatGPT for neurosurgical discharge summaries and operative reports. authored by Joshua Bernstock et. al. Read the publication here! link.springer.com/article/10.100…

Went on an awesome walk this morning! I love the The Board Walks community, elle ✨ is killing it!! 👏 Amazing people and talks during the walk. Max Dordevic bio/acc Bella Taylor

Today we’re excited to announce positive results from the Phase 3 studies of our investigational treatment for moderate-to-severe acute pain. Learn more: news.vrtx.com/news-releases/…

William Clark Brex great! and we both love NeuroX1 Inc. !

Will be in SF today. Who should I connect with?

Innovation and entrepreneurship are the key to Austin’s future.

Shoutout to Sohila Zadran PhD Shai Goldman and the rest of the Brex team for throwing a fantastic Bio Founders/Funders Dinner in Palo Alto last night! Looking forward to the next one!

👉 Discover cutting-edge strategies for combating neurodegenerative diseases in our latest episode featuring Max Dordevic bio/acc, CEO of NeuroX1 Inc. — out now! 🎙️ Experience the revolution in drug discovery with AI and physics-based simulations. 🧠 🎧 hubs.ly/Q02yFQ8j0

Congratulations to Dr. Pablo Valdes Quevedo MD/PhD for hosting a successful optical imaging in neurosurgery conference. Wonderful collaboration between engineers and neurosurgeons Mass General Brigham UTMB Neurosurgery

We spoke with Max Dordevic bio/acc, CEO and co-founder of NeuroX1 Inc., a biotech company revolutionizing drug discovery for neurological diseases through physics-based AI modeling. NeuroX1 is developing innovative approaches to small molecule therapeutics, aiming to accelerate the

God bless medicine and everyone who works in the medical field

I’m primarily in medtech rather than drug development from a regulatory standpoint, so I won’t claim deep expertise in pharmaceuticals. However, I do track the challenges in bringing new therapies to market, and I think we need a nuanced approach. It’s easy to say the FDA should

Today, we’re excited to announce that Oureon is emerging from stealth following a $3.5M pre-seed round led by GTMfund, with participation from Boost VC, BVVC, Ensemble VC, Flyover Capital, JHH VC, and Tiptop VC, to build the future of advanced airspace interoperability.